Clinical trial

Effect of Methylphenidate on Cancer-related Cognitive Impairment

NCT02970500

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2017-10-09

PhasePHASE2

Study timeline

Study start (actual)2017-10-09Date precision: day

Registry last updated2023-03-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancer Femaleunresolved

Cancer-Related Conditionunresolved

Interventions

Methylphenidate HCl 10Mg SRDRUG

Placebo GroupDRUG

Sponsors & collaborators

CHU de Quebec-Universite Lavallead sponsor

Équipe de Recherche Michel-Sarrazin en Oncologie psychosociale et Soins palliatifscollaborator

Purdue Pharma LPcollaborator

Fondation de l'Hôtel-Dieu de Léviscollaborator

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02970500 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.